Inherited variations in drug-metabolizing enzymes: Significance in clinical oncology

Molecular Diagnosis

Volumn 4, Issue 4, 1999, Pages 327-333

  Iyer, Lalitha ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Genotype; Pharmacogenetics; Phenotype; Polymorphism

Indexed keywords

ANTINEOPLASTIC AGENT; DIHYDROPYRIMIDINE DEHYDROGENASE; GLUCURONOSYLTRANSFERASE; THIOPURINE METHYLTRANSFERASE;

CANCER CHEMOTHERAPY; DRUG METABOLISM; DRUG RESPONSE; GENETIC VARIABILITY; HUMAN; PHARMACOGENETICS; PHENOTYPE; REVIEW;

EID: 0033452205     PISSN: 10848592     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1084-8592(99)80009-5     Document Type: Article

References (2)

1. Boddy A, Idle J: The role of pharmacogenetics in chemotherapy: Modulation of tumor response and host toxicity. Cancer Surg 1993;17:79-104
2. Boddy AV, Ratain MJ: Pharmacogenetics in cancer etiology and chemotherapy. Clin Cancer Res 1997; 3:1025-1030